Company intelligence / Profile preview

Cortrium

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

Cortrium has developed and commercialized a CE-marked, medically certified ambulatory ECG monitor (C3+), with over 500,000 ECG reports delivered and more than 8 million hours of ECG analyzed. The device is used by over 2,300 healthcare professionals across multiple countries. Clinical validation studies have been conducted in collaboration with hospitals in Denmark[2][5][7].

Therapeutic areas: Cardiovascular
Modalities: DeviceWearable sensorDigital health platform (ECG analysis software)
Industry: Physiological Monitoring

Partnerships

Pfizer Pharma (commercialization partnership)Bayer HealthCare Grants4Apps accelerator participant

Beyond the preview

Go deeper on Cortrium.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cortrium.

Explore the full profile